John Armitage's NYT Position Overview
John Armitage (via Egerton Capital (Uk) Llp) currently holds 0 shares of The New York Times Company (NYT) worth $0, representing 0.00% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 3 quarters.
Based on 13F filings, John Armitage has maintained this position in NYT for several quarters, showing initial confidence in the investment. Largest reduction occurred in Q2 2026, reducing 971,884 shares.
Analysis based on 13F filings available since 2013 Q2
John Armitage's The New York Times Company (NYT) Holding Value Over Time
Track share changes against reported price movement
Quarterly The New York Times Company (NYT) Trades by John Armitage
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -971,884 | Sold Out | 0 | $0.00 |
| Q1 2026 | -438,119 | Reduce 31.07% | 971,884 | $83.73 |
| Q4 2025 | +1.41 M | New Buy | 1.41 M | $69.42 |
John Armitage's The New York Times Company Investment FAQs
John Armitage first purchased The New York Times Company (NYT) in Q4 2025, acquiring 1,410,003 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Armitage has held The New York Times Company (NYT) for 3 quarters since Q4 2025.
John Armitage's largest addition to The New York Times Company (NYT) was in Q4 2025, adding 1,410,003 shares worth $97.88 M.
According to the latest 13F filing for Q2 2026, John Armitage's firm, Egerton Capital (Uk) Llp, owns 0 shares of The New York Times Company (NYT), valued at approximately $0.
As of the Q2 2026 filing, The New York Times Company (NYT) represents approximately 0.00% of John Armitage's publicly disclosed stock portfolio, making it one of their key holdings.
John Armitage's peak holding in The New York Times Company (NYT) was 1,410,003 shares, as reported at the end of Q4 2025.